Table 2.

Unadjusted and adjusted absolute change (grams per centimeter squared) and percent change in total hip BMD between men and women following hip fracture patients at 2, 6, and 12 months

Time point	Men			Women
Unadjusted	BMD change	95 % CI	*P	BMD change	95 % CI	*P	**P
Baseline	0.8116	(0.7849, 0.8384)	REF	0.7144	(0.6911, 0.7378)	REF	*0.84
Δ T2	−0.0061	(−0.0257, 0.0136)	0.54	−0.0027	(−0.0228, 0.0175)	0.79	0.81
Δ T6	−0.0018	(−0.0293, 0.0257)	0.89	−0.0025	(−0.0273, 0.0223)	0.84	0.97
Δ T12	−0.0189	(−0.0463, 0.0083)	0.17	−0.0022	(−0.0297, 0.0252)	0.87	0.39
Unadjusted	% Change	95 % CI	*P	% Change	95 % CI	*P	**P
Baseline	REF	REF	REF	REF	REF	REF	*0.84
Δ T2	−0.75	(−3.18, 1.68)	0.54	−0.38	(−3.20, 2.45)	0.79	0.81
Δ T6	−0.22	(−3.62, 3.17)	0.89	−0.35	(−3.82, 3.12)	0.84	0.97
Δ T12	−2.35	(−5.72, 1.03)	0.17	−0.32	(−4.16, 3.53)	0.87	0.39
Adjusted	BMD change	95 % CI	*P	BMD change	95 % CI	*P	**P
Baseline	0.7856	(0.7574, 0.8139)	REF	0.7461	(0.7171, 0.7751)	REF	*0.90
Δ T2	−0.0078	(−0.0250, 0.0093)	0.37	−0.003	(−0.0188, 0.0128)	0.70	0.67
Δ T6	−0.0157	(−0.0371, 0.0056)	0.14	−0.0103	(−0.0276, 0.0070)	0.24	0.68
Δ T12	−0.0191	(−0.0441, 0.0058)	0.13	−0.0066	(0.0281, 0.0149)	0.54	0.45
Adjusted	% Change	95 % CI	*P	% Change	95 % CI	*P	**P
Baseline	REF	REF	REF	REF	REF	REF	*0.90
Δ T2	−0.99	(−3.18, 1.18)	0.37	−0.41	(−2.53, 1.72)	0.7	0.67
Δ T6	−2.01	(−4.73, 0.72)	0.14	−1.38	(−3.71, 0.94)	0.24	0.68
Δ T12	−2.44	(−5.61, 0.74)	0.13	−0.88	(−3.77, 2.01)	0.54	0.45

^*P values for the sex- and time-specific changes;

^**P values for the *global test of the sex by time interaction and time-specific sex differences. Adjusted for potential confounders: race, age, weight, height, smoking, alcohol use, bisphosphonates, glucocorticoids, hormone therapy, calcium supplements, comorbidity count, instrumental activities of daily living, center for epidemiologic studies depression scale, and DXA measurement site

BMD bone mineral density, CI confidence interval